Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:748-753

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emery, J. D.
Right arrow Articles by Lawrence, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emery, J. D.
Right arrow Articles by Lawrence, J. B.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:748-753.)
© 1995 American Heart Association, Inc.


Articles

Whole-Blood Platelet Aggregation Predicts In Vitro and In Vivo Primary Hemostatic Function in the Elderly

Jonathan D. Emery; David W. Leifer; Glaci L. Moura; Patricia Southern; James H. Morrissey; Jeffry B. Lawrence

From the Institute of Pathology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio (J.D.E., D.W.L., G.L.M., P.S., J.B.L.), and the Oklahoma Medical Research Foundation, Oklahoma City (J.H.M.).

Abstract Increased platelet aggregation is associated with higher coronary artery disease mortality. Enhanced platelet aggregation in platelet-rich plasma has also been described in the elderly. To define age-related changes in primary hemostasis, we studied 37 elderly and 31 young blood donors. There were no significant age-related differences in whole-blood platelet aggregation, platelet adherence and thrombus formation on human umbilical artery segments, or bleeding time. Plasma fibrinogen was significantly higher in elderly men and women, whereas activated factor VII was elevated only in elderly women. Collagen-induced platelet aggregation was significantly correlated with platelet adherence to the subendothelium in elderly (r=.488, P=.002) but not in young donors. Accordingly, collagen-induced platelet aggregation showed a significant inverse correlation with bleeding time only in the elderly (r=-.401, P=.014). Arachidonic acid–induced platelet aggregation was significantly associated with platelet adherence to the subendothelium (r=.658, P=.003) and bleeding time (r=-.540, P=.021) only in elderly men. In young donors, ADP-induced platelet aggregation was significantly correlated with platelet adherence to the thrombogenic adventitial surface (r=.395, P=.031); in the elderly this association only approached significance (r=.315, P=.058). Whole-blood platelet aggregation in response to collagen and arachidonic acid may be more useful in predicting primary hemostatic function in the elderly than in the young. Furthermore, in the elderly, the correlation between platelet aggregation in whole blood and platelet–arterial wall interactions in vitro and in vivo may contribute to the ability of this test to predict coronary risk.


Key Words: platelet adherence • platelet aggregation • aging • fibrinogen • factor VII




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
C. Velik-Salchner, S. Maier, P. Innerhofer, W. Streif, A. Klingler, C. Kolbitsch, and D. Fries
Point-of-Care Whole Blood Impedance Aggregometry Versus Classical Light Transmission Aggregometry for Detecting Aspirin and Clopidogrel: The Results of a Pilot Study
Anesth. Analg., December 1, 2008; 107(6): 1798 - 1806.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Mascelli, S. Worley, N. J. Veriabo, E. T. Lance, S. Mack, T. Schaible, H. F. Weisman, and R. E. Jordan
Rapid Assessment of Platelet Function With a Modified Whole-Blood Aggregometer in Percutaneous Transluminal Coronary Angioplasty Patients Receiving Anti-GP IIb/IIIa Therapy
Circulation, December 2, 1997; 96(11): 3860 - 3866.
[Abstract] [Full Text]